{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T16:14:57Z","timestamp":1789748097826,"version":"4.0.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,18]]},"DOI":"10.7759\/cureus.116496","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:59:58Z","timestamp":1789747198000},"source":"Crossref","is-referenced-by-count":0,"title":["Earlier Prostatic Artery Embolization for Progressive Benign Prostatic Hyperplasia: A Biological Rationale and Hypothesis for Disease Interception"],"prefix":"10.7759","author":[{"given":"Julian","family":"Sadowski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4103\/0970-1591.126900","article-title":"Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction","volume":"30","author":"Patel ND","year":"2014","unstructured":"Patel ND, Parsons JK. Epidemiology and etiology of benign prostatic hyperplasia and bladder outlet obstruction. Indian J Urol. 2014, 30:170-6. 10.4103\/0970-1591.126900","journal-title":"Indian J Urol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-018-0329-4","article-title":"Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans","volume":"18","author":"Fusco F","year":"2018","unstructured":"Fusco F, Creta M, De Nunzio C, Iacovelli V, Mangiapia F, Li Marzi V, Finazzi Agr\u00f2 E. Progressive bladder remodeling due to bladder outlet obstruction: a systematic review of morphological and molecular evidences in humans. BMC Urol. 2018, 18:15. 10.1186\/s12894-018-0329-4","journal-title":"BMC Urol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)68563-1","article-title":"Incidence rates and risk factors for acute urinary retention: the Health Professionals Follow-up study","volume":"162","author":"Meigs JB","year":"1999","unstructured":"Meigs JB, Barry MJ, Giovannucci E, Rimm EB, Stampfer MJ, Kawachi I. Incidence rates and risk factors for acute urinary retention: the Health Professionals Follow-up study. J Urol. 1999, 162:376-82. 10.1016\/S0022-5347(05)68563-1","journal-title":"J Urol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000046527","article-title":"Postoperative efficacy of transurethral resection of the prostate (TURP) in treating benign prostatic hyperplasia combined with detrusor underactivity","volume":"104","author":"Xin Y","year":"2025","unstructured":"Xin Y, Li D, Lin S, et al.. Postoperative efficacy of transurethral resection of the prostate (TURP) in treating benign prostatic hyperplasia combined with detrusor underactivity. Medicine (Baltimore). 2025, 104:e46527. 10.1097\/MD.0000000000046527","journal-title":"Medicine (Baltimore)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k2338","article-title":"Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial","volume":"361","author":"Abt D","year":"2018","unstructured":"Abt D, Hechelhammer L, M\u00fcllhaupt G, et al.. Comparison of prostatic artery embolisation (PAE) versus transurethral resection of the prostate (TURP) for benign prostatic hyperplasia: randomised, open label, non-inferiority trial. Br Med J. 2018, 361:k2338. 10.1136\/bmj.k2338","journal-title":"Br Med J"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2024.03.001","article-title":"Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic obstruction: 5-year outcomes of a randomised, open-label, noninferiority trial","volume":"10","author":"M\u00fcllhaupt G","year":"2024","unstructured":"M\u00fcllhaupt G, Hechelhammer L, Graf N, Mordasini L, Schmid HP, Engeler DS, Abt D. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic obstruction: 5-year outcomes of a randomised, open-label, noninferiority trial. Eur Urol Focus. 2024, 10:788-95. 10.1016\/j.euf.2024.03.001","journal-title":"Eur Urol Focus"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003698","article-title":"Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline Amendment 2023","volume":"211","author":"Sandhu JS","year":"2024","unstructured":"Sandhu JS, Bixler BR, Dahm P, Goueli R, Kirkby E, Stoffel JT, Wilt TJ. Management of lower urinary tract symptoms attributed to benign prostatic hyperplasia (BPH): AUA guideline Amendment 2023. J Urol. 2024, 211:11-9. 10.1097\/JU.0000000000003698","journal-title":"J Urol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia","volume":"349","author":"McConnell JD","year":"2003","unstructured":"McConnell JD, Roehrborn CG, Bautista OM, et al.. The long-term effect of doxazosin, finasteride, and combination therapy on the clinical progression of benign prostatic hyperplasia. N Engl J Med. 2003, 349:2387-98. 10.1056\/NEJMoa030656","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2009.09.035","article-title":"The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study","volume":"57","author":"Roehrborn CG","year":"2010","unstructured":"Roehrborn CG, Siami P, Barkin J, et al.. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic benign prostatic hyperplasia: 4-year results from the CombAT study. Eur Urol. 2010, 57:123-31. 10.1016\/j.eururo.2009.09.035","journal-title":"Eur Urol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2014.11.006","article-title":"Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study","volume":"68","author":"Cindolo L","year":"2015","unstructured":"Cindolo L, Pirozzi L, Fanizza C, et al.. Drug adherence and clinical outcomes for patients under pharmacological therapy for lower urinary tract symptoms related to benign prostatic hyperplasia: population-based cohort study. Eur Urol. 2015, 68:418-25. 10.1016\/j.eururo.2014.11.006","journal-title":"Eur Urol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.21037\/tau.2017.03.57","article-title":"The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia","volume":"6","author":"Gandhi J","year":"2017","unstructured":"Gandhi J, Weissbart SJ, Smith NL, et al.. The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia. Transl Androl Urol. 2017, 6:295-304. 10.21037\/tau.2017.03.57","journal-title":"Transl Androl Urol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2016.10.071","article-title":"The American Urological Association symptom index for benign prostatic hyperplasia","volume":"197","author":"Barry MJ","year":"2017","unstructured":"Barry MJ, Fowler FJ Jr, O'Leary MP, et al.. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 2017, 197:S189-97. 10.1016\/j.juro.2016.10.071","journal-title":"J Urol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/nau.24076","article-title":"Do functional changes occur in the bladder due to bladder outlet obstruction? - ICI-RS 2018","volume":"38","author":"Bosch R","year":"2019","unstructured":"Bosch R, Abrams P, Averbeck MA, Finazzi Agr\u00f3 E, Gammie A, Marcelissen T, Solomon E. Do functional changes occur in the bladder due to bladder outlet obstruction? - ICI-RS 2018. Neurourol Urodyn. 2019, 38:S56-65. 10.1002\/nau.24076","journal-title":"Neurourol Urodyn"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2011.10430.x","article-title":"Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia","volume":"109","author":"Fitzpatrick JM","year":"2012","unstructured":"Fitzpatrick JM, Desgrandchamps F, Adjali K, Gomez Guerra L, Hong SJ, El Khalid S, Ratana-Olarn K. Management of acute urinary retention: a worldwide survey of 6074 men with benign prostatic hyperplasia. BJU Int. 2012, 109:88-95. 10.1111\/j.1464-410X.2011.10430.x","journal-title":"BJU Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.369","article-title":"Immediate or delayed trial without catheter in acute urinary retention in males: a systematic review","volume":"5","author":"Christensen VS","year":"2024","unstructured":"Christensen VS, Skow M, Flottorp SA, Str\u00f8mme H, Mdala I, Vallersnes OM. Immediate or delayed trial without catheter in acute urinary retention in males: a systematic review. BJUI Compass. 2024, 5:846-61. 10.1002\/bco2.369","journal-title":"BJUI Compass"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39377.617269.55","article-title":"Mortality in men admitted to hospital with acute urinary retention: database analysis","volume":"335","author":"Armitage JN","year":"2007","unstructured":"Armitage JN, Sibanda N, Cathcart PJ, Emberton M, Meulen JH. Mortality in men admitted to hospital with acute urinary retention: database analysis. Br Med J. 2007, 335:1199-202. 10.1136\/bmj.39377.617269.55","journal-title":"Br Med J"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)64843-4","article-title":"Blood flow, pressure and compliance in the male human bladder","volume":"168","author":"Kershen RT","year":"2002","unstructured":"Kershen RT, Azadzoi KM, Siroky MB. Blood flow, pressure and compliance in the male human bladder. J Urol. 2002, 168:121-5. 10.1016\/S0022-5347(05)64843-4","journal-title":"J Urol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000139986.08972.e3","article-title":"Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction","volume":"172","author":"Mirone V","year":"2004","unstructured":"Mirone V, Imbimbo C, Sessa G, Palmieri A, Longo N, Granata AM, Fusco F. Correlation between detrusor collagen content and urinary symptoms in patients with prostatic obstruction. J Urol. 2004, 172:1386-9. 10.1097\/01.ju.0000139986.08972.e3","journal-title":"J Urol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-024-01417-8","article-title":"De-obstruction of bladder outlet in humans reverses organ remodelling by normalizing the expression of key transcription factors","volume":"24","author":"Akshay A","year":"2024","unstructured":"Akshay A, Gheinani AH, Besic M, et al.. De-obstruction of bladder outlet in humans reverses organ remodelling by normalizing the expression of key transcription factors. BMC Urol. 2024, 24:33. 10.1186\/s12894-024-01417-8","journal-title":"BMC Urol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2023.100672","article-title":"Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial","volume":"31","author":"Sapoval M","year":"2023","unstructured":"Sapoval M, Thiounn N, Descazeaud A, et al.. Prostatic artery embolisation versus medical treatment in patients with benign prostatic hyperplasia (PARTEM): a randomised, multicentre, open-label, phase 3, superiority trial. Lancet Reg Health Eur. 2023, 31:100672. 10.1016\/j.lanepe.2023.100672","journal-title":"Lancet Reg Health Eur"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16479","article-title":"The 'prostate embolisation as first-line therapy compared to medication in treatment na\u00efve men with prostate enlargement, a randomised controlled trial' (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH","volume":"134","author":"Brown N","year":"2024","unstructured":"Brown N, Kiosoglous A, Castree S, et al.. The 'prostate embolisation as first-line therapy compared to medication in treatment na\u00efve men with prostate enlargement, a randomised controlled trial' (P-EASY ADVANCE): a randomised controlled trial of prostate embolisation vs medication for BPH. BJU Int. 2024, 134:38-46. 10.1111\/bju.16479","journal-title":"BJU Int"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2024.11.002","article-title":"Prostatic artery embolization: mid- to long-term outcomes in 1,075 patients","volume":"36","author":"Bhatia S","year":"2025","unstructured":"Bhatia S, Bhatia A, Richardson AJ, et al.. Prostatic artery embolization: mid- to long-term outcomes in 1,075 patients. J Vasc Interv Radiol. 2025, 36:456-66. 10.1016\/j.jvir.2024.11.002","journal-title":"J Vasc Interv Radiol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.11.010","article-title":"Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia","volume":"77","author":"Pisco JM","year":"2020","unstructured":"Pisco JM, Bilhim T, Costa NV, Torres D, Pisco J, Pinheiro LC, Oliveira AG. Randomised clinical trial of prostatic artery embolisation versus a sham procedure for benign prostatic hyperplasia. Eur Urol. 2020, 77:354-62. 10.1016\/j.eururo.2019.11.010","journal-title":"Eur Urol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16808","article-title":"Prostate artery embolisation safety and efficacy: preliminary and follow-up urodynamic studies (P-EASY PLUS)","volume":"136","author":"Brown N","year":"2025","unstructured":"Brown N, Firouzmand S, Kiosoglous A, et al.. Prostate artery embolisation safety and efficacy: preliminary and follow-up urodynamic studies (P-EASY PLUS). BJU Int. 2025, 136:S54-61. 10.1111\/bju.16808","journal-title":"BJU Int"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.02.008","article-title":"Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-year outcomes of a randomised, open-label, single-centre trial","volume":"80","author":"Abt D","year":"2021","unstructured":"Abt D, M\u00fcllhaupt G, Hechelhammer L, et al.. Prostatic artery embolisation versus transurethral resection of the prostate for benign prostatic hyperplasia: 2-year outcomes of a randomised, open-label, single-centre trial. Eur Urol. 2021, 80:34-42. 10.1016\/j.eururo.2021.02.008","journal-title":"Eur Urol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-022-04225-7","article-title":"Prostatic arterial embolization versus holmium laser enucleation of the prostate: 1-year outcomes","volume":"41","author":"Seizilles de Mazancourt E","year":"2023","unstructured":"Seizilles de Mazancourt E, Pagnoux G, Codas Duarte R, et al.. Prostatic arterial embolization versus holmium laser enucleation of the prostate: 1-year outcomes. World J Urol. 2023, 41:151-7. 10.1007\/s00345-022-04225-7","journal-title":"World J Urol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1002\/bco2.302","article-title":"One-year outcomes after prostate artery embolization versus laser enucleation: a network meta-analysis","volume":"5","author":"Bhatia A","year":"2024","unstructured":"Bhatia A, Porto JG, Maini A, Langade D, Herrmann TR, Shah HN, Bhatia S. One-year outcomes after prostate artery embolization versus laser enucleation: a network meta-analysis. BJUI Compass. 2024, 5:189-206. 10.1002\/bco2.302","journal-title":"BJUI Compass"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1007\/s00270-024-03802-0","article-title":"Two-year outcomes of prostatic artery embolization for symptomatic benign prostatic hyperplasia: an international, multicenter, prospective study","volume":"47","author":"Sapoval MR","year":"2024","unstructured":"Sapoval MR, Bhatia S, D\u00e9an C, et al.. Two-year outcomes of prostatic artery embolization for symptomatic benign prostatic hyperplasia: an international, multicenter, prospective study. Cardiovasc Intervent Radiol. 2024, 47:1515-24. 10.1007\/s00270-024-03802-0","journal-title":"Cardiovasc Intervent Radiol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1186\/s13643-024-02514-3","article-title":"Transurethral surgical treatment for benign prostatic hyperplasia with detrusor underactivity: a systematic review and meta-analysis","volume":"13","author":"Zou P","year":"2024","unstructured":"Zou P, Liu C, Zhang Y, et al.. Transurethral surgical treatment for benign prostatic hyperplasia with detrusor underactivity: a systematic review and meta-analysis. Syst Rev. 2024, 13:93. 10.1186\/s13643-024-02514-3","journal-title":"Syst Rev"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(05)63949-3","article-title":"The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction","volume":"169","author":"de Nunzio C","year":"2003","unstructured":"de Nunzio C, Franco G, Rocchegiani A, Iori F, Leonardo C, Laurenti C. The evolution of detrusor overactivity after watchful waiting, medical therapy and surgery in patients with bladder outlet obstruction. J Urol. 2003, 169:535-9. 10.1016\/S0022-5347(05)63949-3","journal-title":"J Urol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1038\/pcan.2013.11","article-title":"The incidence of acute urinary retention secondary to BPH is increasing among California men","volume":"16","author":"Groves HK","year":"2013","unstructured":"Groves HK, Chang D, Palazzi K, Cohen S, Parsons JK. The incidence of acute urinary retention secondary to BPH is increasing among California men. Prostate Cancer Prostatic Dis. 2013, 16:260-5. 10.1038\/pcan.2013.11","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/pros.24440","article-title":"Acute urinary retention in men: 21-year trends in incidence, subsequent benign prostatic hyperplasia-related treatment and mortality: a Danish population-based cohort study","volume":"83","author":"Bengtsen MB","year":"2023","unstructured":"Bengtsen MB, Heide-J\u00f8rgensen U, Borre M, Knudsen JS, N\u00f8rgaard M. Acute urinary retention in men: 21-year trends in incidence, subsequent benign prostatic hyperplasia-related treatment and mortality: a Danish population-based cohort study. Prostate. 2023, 83:87-96. 10.1002\/pros.24440","journal-title":"Prostate"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/530019-earlier-prostatic-artery-embolization-for-progressive-benign-prostatic-hyperplasia-a-biological-rationale-and-hypothesis-for-disease-interception","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T15:59:59Z","timestamp":1789747199000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/530019-earlier-prostatic-artery-embolization-for-progressive-benign-prostatic-hyperplasia-a-biological-rationale-and-hypothesis-for-disease-interception"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":32,"URL":"https:\/\/doi.org\/10.7759\/cureus.116496","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}